NASDAQ:VANI Vivani Medical (VANI) Stock Price, News & Analysis → Does this make you sick? (From Allegiance Gold) (Ad) Free VANI Stock Alerts $1.83 -0.02 (-1.08%) (As of 05/14/2024 ET) Add Compare Share Share Today's Range$1.74▼$1.8750-Day Range$1.62▼$2.2152-Week Range$0.84▼$7.80Volume300,612 shsAverage Volume91,792 shsMarket Capitalization$100.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Vivani Medical alerts: Email Address Vivani Medical MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.33% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.31Based on 7 Articles This WeekInsider TradingAcquiring Shares$1,089 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.61 out of 5 starsMedical Sector881st out of 928 stocksElectromedical Equipment Industry20th out of 21 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Vivani Medical.Read more about Vivani Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.33% of the float of Vivani Medical has been sold short.Short Interest Ratio / Days to CoverVivani Medical has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vivani Medical has recently increased by 18.49%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldVivani Medical does not currently pay a dividend.Dividend GrowthVivani Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for VANI. Previous Next 2.4 News and Social Media Coverage News SentimentVivani Medical has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Vivani Medical this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for VANI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Vivani Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vivani Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,089.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders55.62% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 6.78% of the stock of Vivani Medical is held by institutions.Read more about Vivani Medical's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Vivani Medical is -3.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vivani Medical is -3.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVivani Medical has a P/B Ratio of 4.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Vivani Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Vivani Medical Stock (NASDAQ:VANI)Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.Read More VANI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VANI Stock News HeadlinesMay 13 at 8:52 PM | investorplace.comVANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024May 13 at 4:45 PM | businesswire.comVivani Medical Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 13 at 4:47 AM | americanbankingnews.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Rises By 18.5%May 9, 2024 | finance.yahoo.comVivani Medical to Present at TIDES Conference 2024March 26, 2024 | sfgate.comVivani Medical: Q4 Earnings SnapshotMarch 26, 2024 | finance.yahoo.comVivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 26, 2024 | finance.yahoo.comVivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 26, 2024 | investorplace.comVANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023March 16, 2024 | finance.yahoo.comVANI May 2024 6.000 callMarch 16, 2024 | finance.yahoo.comVANI Aug 2024 6.000 callMarch 16, 2024 | finance.yahoo.comVANI Apr 2024 1.000 callMarch 9, 2024 | morningstar.comThinking about buying stock in Ocean Biomedical, Rush Street Interactive, Vivani Medical, Abeona Therapeutics, or Honest Company?March 6, 2024 | finance.yahoo.comVivani Medical Appoints Daniel Bradbury to its Board of DirectorsMarch 4, 2024 | msn.comVivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare moversMarch 3, 2024 | finance.yahoo.comVANI Mar 2024 2.500 putMarch 1, 2024 | msn.comVivani Medical announces pricing of $15M registered direct offeringMarch 1, 2024 | marketwatch.comVivani Medical Shares Retreat 20% on Securities Purchase AgreementMarch 1, 2024 | markets.businessinsider.comVivani Medical Prices $15 Mln Direct Offering; Stock Down Over 20% In Pre-marketMarch 1, 2024 | businesswire.comVivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and WarrantsMarch 1, 2024 | finance.yahoo.comIndividual investors invested in Vivani Medical, Inc. (NASDAQ:VANI) up 287% last week, insiders too were rewardedFebruary 29, 2024 | ca.news.yahoo.comDoctors, advocates hail federal diabetes drug plan as potentially 'life-changing'February 29, 2024 | ca.news.yahoo.comIt's not 'all in their head.' Heart disease is misdiagnosed in women. And it's killing us.February 28, 2024 | msn.comVivani Medical surges after animal data on obesity implantsFebruary 28, 2024 | investorplace.comWhy Is Vivani Medical (VANI) Stock Up 300% Today?February 28, 2024 | finance.yahoo.comVivani Medical Shows Preclinical Data on Weight Loss ImplantsSee More Headlines Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/26/2024Today5/15/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:VANI CUSIPN/A CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees44Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,650,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-95.91% Return on Assets-47.96% Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio4.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.41 per share Price / Book4.46Miscellaneous Outstanding Shares54,980,000Free Float24,399,000Market Cap$100.61 million OptionableOptionable Beta3.26 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Adam Mendelsohn Ph.D. (Age 42)Co-Founder, CEO & Director Comp: $312.01kMs. Brigid Ann Makes (Age 68)Chief Financial Officer Comp: $204.63kMr. Truc Le M.B.A. (Age 71)Chief Operations Officer Comp: $337.2kDr. Lisa E. Porter M.D. (Age 60)Chief Medical Officer Comp: $208.4kMr. Donald Dwyer M.B.A.Chief Business OfficerKey CompetitorsFONARNASDAQ:FONRHyperfineNASDAQ:HYPRElectromedNYSE:ELMDelectroCoreNASDAQ:ECORMovanoNASDAQ:MOVEView All CompetitorsInsiders & InstitutionsTanager Wealth Management LLPSold 348,222 shares on 5/1/2024Ownership: 2.370%Commonwealth Equity Services LLCSold 9,500 shares on 4/30/2024Ownership: 0.638%Gregg WilliamsBought 1,078 shares on 2/15/2024Total: $1,088.78 ($1.01/share)Gregg WilliamsBought 1,119 shares on 2/8/2024Total: $1,130.19 ($1.01/share)Gregg WilliamsBought 100 shares on 1/31/2024Total: $101.00 ($1.01/share)View All Insider TransactionsView All Institutional Transactions VANI Stock Analysis - Frequently Asked Questions How have VANI shares performed in 2024? Vivani Medical's stock was trading at $1.02 at the beginning of 2024. Since then, VANI stock has increased by 79.4% and is now trading at $1.83. View the best growth stocks for 2024 here. When is Vivani Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our VANI earnings forecast. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) posted its earnings results on Tuesday, March, 26th. The company reported ($0.12) EPS for the quarter. Who are Vivani Medical's major shareholders? Vivani Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Tanager Wealth Management LLP (2.37%) and Commonwealth Equity Services LLC (0.64%). Insiders that own company stock include Aaron Mendelsohn, Brigid Makes, Donald Dwyer, Gregg Williams and Joachim Eberhard Bolck. View institutional ownership trends. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:VANI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHow to Make 100X on the AI BoomInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
